NCT06696768
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06696768
Title Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UF Health Cancer Institute - Gainesville RECRUITING Gainesville Florida 32610 United States Details
Memorial Hospital East RECRUITING Shiloh Illinois 62269 United States Details
University of Kansas Clinical Research Center RECRUITING Fairway Kansas 66205 United States Details
University of Kansas Cancer Center RECRUITING Kansas City Kansas 66160 United States Details
University of Kansas Hospital-Indian Creek Campus RECRUITING Overland Park Kansas 66211 United States Details
University of Kansas Hospital-Westwood Cancer Center RECRUITING Westwood Kansas 66205 United States Details
Siteman Cancer Center at Saint Peters Hospital RECRUITING City of Saint Peters Missouri 63376 United States Details
Siteman Cancer Center at West County Hospital RECRUITING Creve Coeur Missouri 63141 United States Details
Washington University School of Medicine RECRUITING St Louis Missouri 63110 United States Details
Siteman Cancer Center-South County RECRUITING St Louis Missouri 63129 United States Details
Siteman Cancer Center at Christian Hospital RECRUITING St Louis Missouri 63136 United States Details
University of Oklahoma Health Sciences Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
Vanderbilt University/Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field